| |
| Please Note - Streaming News is only available to subscribers to the Active Level and above |
|
|
|
RNS News Service
I confirm that I am accessing this story in my capacity as a private investor and NOT for professional purposes.
Willis Towers Watson plc 8.3
RNS
|
RNS Number : 8241C
J.P. Morgan Securities LLC
21 October 2020
Ap19
FORM
8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1.
KEY
INFORMATION
|
Nameofpersondealing
(Note
1)
|
J.P. Morgan Securities LLC
|
|
Companydealtin
|
Willis Towers Watson plc
|
|
Classofrelevantsecuritytowhichthe dealingsbeingdisclosedrelate
(Note
2)
|
US$0.000304635 ordinary shares
|
|
Date
of
dealing
|
20 October 2020
|
2.
INTERESTS AND SHORT POSITIONS
(a)
Interests
and
short
positions
(following
dealing)
in
the
class
of
relevant
security
dealt
in
(Note
3)
|
|
Long
|
Short
|
|
|
Number
|
|
(%)
|
Number
|
|
(%)
|
|
(1)Relevantsecurities
|
2,561,305 1.99
|
2,284,857 1.77
|
|
(2)
Derivatives
(other
than
options)
|
2,312,422 1.79
|
2,238,102 1.74
|
|
(3)Optionsandagreementstopurchase/sell
|
|
|
|
Total
|
4,873,727 3.78
|
4,522,959 3.51
|
| |
|
|
|
|
|
|
Ap20
1.
DEALINGS
(Note
4)
(a) Purchases and sales
|
Purchase/sale
|
Numberofrelevantsecurities
|
Priceperunit(USD)
(Note
5)
|
|
Purchase (New Borrow)
Purchase
Sale
|
215,400
100
7,263
91
36
100
100
100
100
100
100
32
100
332
300
100
24
100
100
100
31
100
100
100
117
29
3,090
100
1,200
4
1,164
5
3
2,151
100
2,189
100
57
100
100
1
1
2,538
180
200
11
100
200
100
2,790
100
100
100
1
200
76,405
30
91
61
200
100
200
200
100
100
200
100
64
200
600
4
5
200
200
200
200
1
31
100
200
100
200
6
234
4
4
29
5
3,090
124
100
1,200
2
10
1
200
8
200
115
2
200
100
1
360
400
1
23
200
200
2,790
200
200
100
|
NA
209.2100
209.4000
209.6167
209.6750
209.9300
209.9600
210.2300
210.2600
210.4500
210.5300
210.5400
210.5600
210.5761
210.5800
210.7800
210.8400
210.8700
211.0200
211.0600
211.1136
211.1400
211.2000
211.2100
211.2500
211.5352
211.5738
211.6500
211.8198
211.8250
211.8810
212.1600
212.2800
212.3100
212.3500
212.4300
212.4500
212.4900
212.5400
212.7000
212.7100
212.8700
212.9200
212.9300
212.9400
213.0900
213.1300
213.2436
213.2438
213.2600
213.5300
213.5900
213.7000
214.7250
209.2100
209.4000
209.6100
209.6167
209.6200
209.9300
209.9600
210.1100
210.2300
210.2600
210.4500
210.4900
210.5300
210.5400
210.5600
210.5800
210.6325
210.6600
210.7800
210.8700
211.0200
211.0600
211.0700
211.1136
211.1400
211.1700
211.2000
211.2100
211.2450
211.2500
211.4250
211.4625
211.5352
211.5600
211.5738
211.6268
211.6500
211.8198
211.9250
212.1600
212.2900
212.3500
212.4200
212.4500
212.4900
212.4950
212.5400
212.7000
212.7100
212.9300
212.9400
212.9500
213.0900
213.1300
213.2000
213.2600
213.5300
213.5900
213.7000
|
(b) Derivatives transactions (other than options transactions)
|
Productname,
e.g.
CFD
|
Natureoftransaction
(Note
6)
|
Numberofrelevantsecurities
(Note
7)
|
Priceperunit
(USD)
(Note
5)
|
|
Equity Swap
|
Long
Short
|
162,513
31
1,200
|
209.4000
211.1136
211.8198
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
|
Productname,
e.g.
call
option
|
Writing,
selling,purchasing,varyingetc.
|
Numberofsecurities towhichtheoptionrelates
(Note
7)
|
Exercise price
|
Type,
e.g.American,Europeanetc.
|
Expiry date
|
Optionmoney paid/receivedperunit
(Note
5)
|
|
|
|
|
|
|
|
|
(ii) Exercising
|
Productname,
e.g.
call
option
|
Numberofsecurities
|
Exercisepriceper unit
(Note
5)
|
|
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
|
Nature
of
transaction
(Note
8)
|
Details
|
Price
per
unit
(if applicable)
(Note 5)
|
|
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and
any other person relating to the voting rights of any relevant securities under any option referred to
on
this
form
or
relating
to
the
voting
rights
or
future
acquisition
or
disposal
of
any
relevant securities to
which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 attached?
(Note
9)
NO
|
Dateofdisclosure
|
21 October 2020
|
|
Contact
name
|
Alwyn Basch
|
|
Telephone
number
|
0207 742 7407
|
|
If
aconnectedEFM,nameofofferee/offerorwithwhichconnected
|
N/A
|
|
If
aconnectedEFM,statenatureofconnection
(Note
10)
|
N/A
|
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com. RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END
ISEXFLFLBBLZFBE
|
|
|
|
|
|
